Leading Swiss firms Homburger and Lenz & Staehelin have scooped the lead roles advising on German drug company Merck’s E11.5bn (£7.7bn) acquisition of Swiss biotech firm Serono.

The deal, which is understood to be the biggest takeover of a Swiss company by a foreign investor, was carried out under Swiss law.